Leonid Timashev
Stock Analyst at RBC Capital
(0)
# 3809
Out of 5,218 analysts
59
Total ratings
38.89%
Success rate
-0.07%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Legend Biotech | Reiterates: Outperform | 86 86 | 35.19 | 144.39% | 12 | Dec 9, 2024 | |
Biohaven | Reiterates: Outperform | 58 61 | 38.47 | 58.57% | 9 | Dec 4, 2024 | |
Pyxis Oncology | Maintains: Outperform | 7 10 | 1.63 | 513.5% | 4 | Nov 21, 2024 | |
Cytokinetics | Initiates Coverage On: Outperform | 80 | 48.66 | 64.41% | 1 | Nov 8, 2024 | |
Compass Pathways | Maintains: Outperform | 23 18 | 4.22 | 326.54% | 3 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 130 131 | 90.01 | 45.54% | 7 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 32 42 | 27.61 | 52.12% | 9 | Sep 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 31 31 | 24.49 | 26.58% | 5 | Sep 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Sector Perform | 4 4 | 5.57 | -28.19% | 8 | Aug 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Sector Perform | 240 20 | n/a | n/a | 1 | Oct 18, 2022 |